Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

A Non-targeted Metabolomics Reveals Therapeutical Effect and Mechanism of Sanmiao Pill on Adjuvant-induced Arthritis Rats

Author(s): Dongdong Cao, Le Yang, Xin Gao, Danna Huang, Xiaoning Zhan, Shi Qiu, Hui Sun, Guangli Yan and Xijun Wang*

Volume 29, Issue 17, 2023

Published on: 12 June, 2023

Page: [1379 - 1389] Pages: 11

DOI: 10.2174/1381612829666230511161308

Price: $65

conference banner
Abstract

Background and Objective: Rheumatoid arthritis (RA) is an increasingly serious disease worldwide that can damage the joints and bones of sufferers. Sanmiao Pill (SMP), a classical traditional Chinese medicine (TCM) prescription, has been used for effective treatments for RA in the clinic. To comprehensively illuminate the therapeutic mechanism of SMP in the treatment of RA, the effects of SMP on biomarkers and metabolic pathways in rats with adjuvant-induced arthritis (AIA) were examined.

Methods: Sprague Dawley rats were randomly divided into two control (CC, Control) groups, two model (MM, Model) groups, a methotrexate group (MTX, 7.6 mg/kg body weight per week), and two SMP groups (San-L, 28.7 mg/kg body weight per day and San-H, 57.4 mg/kg body weight per day). Rats' body weight, paw swelling, arthritis scores, biochemical parameters, histopathology, and so on were used to evaluate the success of the model and the therapeutic effects of SMP. The metabolic techniques were used to characterize the metabolic profile and biomarkers of the serum and urine samples of rats to reveal the metabolic changes that occurred after SMP treatment.

Results: After 21 days of treatment, SMP improved weight gain, reduced the severity of paw swelling, lowered the levels of biochemical indicators (CCP-Ab, IL-6, TNF-α, RF), decreased destruction of articular cartilage and bone erosion, and protected the affected joints.Additionally, 17 and 19 potential biomarkers associated with RA were identified in the serum and urine, respectively. SMP significantly reversed 14 potential biomarkers, such as arachidonic acid, lysoPC(20:4(5Z,8Z,11Z,14Z)), L-tryptophan, 9-cis-Retinoic acid, hippuric acid, pyridoxine, and pantothenic acid. These metabolites are associated with arachidonic acid metabolism, glycerophospholipid catabolism, tryptophan metabolism, phenylalanine metabolism, vitamin B6 metabolism, etc.

Conclusion: These results indicated that RA-related biomarkers reflected the metabolic profile of AIA rats. Meanwhile, SMP could effectively treat RA mainly by reducing inflammation and regulating abnormal lipid metabolic pathways and amino acid metabolisms. It showed that metabolomics could be used to analyze the metabolic profiles involved in RA and reveal the mechanism of SMP treatment of RA.

« Previous
[1]
Weyand CM, Goronzy JJ. Immunometabolism in early and late stages of rheumatoid arthritis. Nat Rev Rheumatol 2017; 13(5): 291-301.
[http://dx.doi.org/10.1038/nrrheum.2017.49] [PMID: 28360422]
[2]
Croia C, Bursi R, Sutera D, Petrelli F, Alunno A, Puxeddu I. One year in review 2019: Pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 2019; 37(3): 347-57.
[PMID: 31111823]
[3]
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016; 388(10055): 2023-38.
[http://dx.doi.org/10.1016/S0140-6736(16)30173-8] [PMID: 27156434]
[4]
Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis. JAMA 2018; 320(13): 1360-72.
[http://dx.doi.org/10.1001/jama.2018.13103] [PMID: 30285183]
[5]
Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis JM III. Comorbidities as risk factors for rheumatoid arthritis and their accrual after diagnosis. Mayo Clin Proc 2019; 94(12): 2488-98.
[http://dx.doi.org/10.1016/j.mayocp.2019.08.010] [PMID: 31759675]
[6]
Lacaille D, Avina-Zubieta JA, Sayre EC, Abrahamowicz M. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population—closing the mortality gap. Ann Rheum Dis 2017; 76(6): 1057-63.
[http://dx.doi.org/10.1136/annrheumdis-2016-209562] [PMID: 28031164]
[7]
Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers 2018; 4(1): 18001.
[http://dx.doi.org/10.1038/nrdp.2018.1] [PMID: 29417936]
[8]
Lin YJ, Anzaghe M, Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells 2020; 9(4): 880.
[http://dx.doi.org/10.3390/cells9040880] [PMID: 32260219]
[9]
Pan HD, Xiao Y, Wang WY, Ren RT, Leung ELH, Liu L. Traditional chinese medicine as a treatment for rheumatoid arthritis: From empirical practice to evidence-based therapy. Engineering 2019; 5(5): 895-906.
[http://dx.doi.org/10.1016/j.eng.2019.01.018]
[10]
Li T, Zhang A, Miao J, et al. Applications and potential mechanisms of herbal medicines for rheumatoid arthritis treatment: A systematic review. RSC Advances 2019; 9(45): 26381-92.
[http://dx.doi.org/10.1039/C9RA04737A] [PMID: 35685403]
[11]
Wang Y, Chen S, Du K, et al. Traditional herbal medicine: Therapeutic potential in rheumatoid arthritis. J Ethnopharmacol 2021; 279: 114368.
[http://dx.doi.org/10.1016/j.jep.2021.114368] [PMID: 34197960]
[12]
Wang H, Yan G, Zhang A, et al. Rapid discovery and global characterization of chemical constituents and rats metabolites of Phellodendri amurensis cortex by ultra-performance liquid chromatography-electrospray ionization/quadrupole-time-of-flight mass spectrometry coupled with pattern recognition approach. Analyst 2013; 138(11): 3303-12.
[http://dx.doi.org/10.1039/c3an36902a] [PMID: 23608925]
[13]
Jun X, Fu P, Lei Y, Cheng P. Pharmacological effects of medicinal components of Atractylodes lancea (Thunb.) DC. Chin Med 2018; 13(1): 59.
[http://dx.doi.org/10.1186/s13020-018-0216-7] [PMID: 30505341]
[14]
He X, Wang X, Fang J, et al. The genus Achyranthes : A review on traditional uses, phytochemistry, and pharmacological activities. J Ethnopharmacol 2017; 203: 260-78.
[http://dx.doi.org/10.1016/j.jep.2017.03.035] [PMID: 28347832]
[15]
Zou D, Zhang A, Yan G, Tan Y, Sun H, Wang X. UPLC-MS coupled with a dynamic multiple data processing method for the comprehensive detection of the chemical constituents of the herbal formula San-Miao-Wan. Anal Methods 2014; 6(9): 2848-54.
[http://dx.doi.org/10.1039/c3ay41814f]
[16]
Li EK, Tam LS, Wong CK, et al. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: A double-blind, randomized, placebo-controlled pilot trial. Arthritis Rheum 2007; 57(7): 1143-50.
[http://dx.doi.org/10.1002/art.22994] [PMID: 17907228]
[17]
Xi BY, Kwok WC, Kwok MLE, et al. Immunomodulatory effects of lingzhi and san-miao-san supplementation on patients with rheumatoid arthritis. Immunopharmacol Immunotoxicol 2006; 28(2): 197-200.
[http://dx.doi.org/10.1080/08923970600815097] [PMID: 16873089]
[18]
Bujak R, Struck-Lewicka W, Markuszewski MJ, Kaliszan R. Metabolomics for laboratory diagnostics. J Pharm Biomed Anal 2015; 113: 108-20.
[http://dx.doi.org/10.1016/j.jpba.2014.12.017] [PMID: 25577715]
[19]
Pang H, Jia W, Hu Z. Emerging applications of metabolomics in clinical pharmacology. Clin Pharmacol Ther 2019; 106(3): 544-56.
[http://dx.doi.org/10.1002/cpt.1538] [PMID: 31173340]
[20]
Zhang AH, Sun H, Yan GL, Han Y, Zhao QQ, Wang XJ. Chinmedomics: A powerful approach integrating metabolomics with serum pharmacochemistry to evaluate the efficacy of traditional chinese medicine. Engineering 2019; 5(1): 60-8.
[http://dx.doi.org/10.1016/j.eng.2018.11.008]
[21]
Zhang A, Sun H, Yan G, Wang P, Wang X. Mass spectrometry-based metabolomics: Applications to biomarker and metabolic pathway research. Biomed Chromatogr 2016; 30(1): 7-12.
[http://dx.doi.org/10.1002/bmc.3453] [PMID: 25739660]
[22]
Qiu S, Zhang A, Guan Y, et al. Functional metabolomics using UPLC-Q/TOF-MS combined with ingenuity pathway analysis as a promising strategy for evaluating the efficacy and discovering amino acid metabolism as a potential therapeutic mechanism-related target for geniposide against alcoholic liver disease. RSC Advances 2020; 10(5): 2677-90.
[http://dx.doi.org/10.1039/C9RA09305B] [PMID: 35496090]
[23]
Sun H, Zhang A, Yang L, et al. High-throughput chinmedomics strategy for discovering the quality-markers and potential targets for Yinchenhao decoction. Phytomedicine 2019; 54: 328-38.
[http://dx.doi.org/10.1016/j.phymed.2018.04.015] [PMID: 30340940]
[24]
Zhang AH, Yu JB, Sun H, et al. Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer’s disease using chinmedomics approach. Phytomedicine 2018; 45: 84-92.
[http://dx.doi.org/10.1016/j.phymed.2018.04.004] [PMID: 29685366]
[25]
Li R, Guo LX, Li Y, et al. Dose-response characteristics of Clematis triterpenoid saponins and clematichinenoside AR in rheumatoid arthritis rats by liquid chromatography/mass spectrometry-based serum and urine metabolomics. J Pharm Biomed Anal 2017; 136: 81-91.
[http://dx.doi.org/10.1016/j.jpba.2016.12.037] [PMID: 28064091]
[26]
Chen Z, Bozec A, Ramming A, Schett G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol 2019; 15(1): 9-17.
[http://dx.doi.org/10.1038/s41584-018-0109-2] [PMID: 30341437]
[27]
Qian H, Jin Q, Liu Y, et al. Study on the multitarget mechanism of sanmiao pill on gouty arthritis based on network pharmacology. Evid Based Complement Alternat Med 2020; 2020: 1-11.
[http://dx.doi.org/10.1155/2020/9873739] [PMID: 32831884]
[28]
Li XX, Han M, Wang YY, Liu JP. Chinese herbal medicine for gout: A systematic review of randomized clinical trials. Clin Rheumatol 2013; 32(7): 943-59.
[http://dx.doi.org/10.1007/s10067-013-2274-7] [PMID: 23666318]
[29]
Li C, Chen B, Fang Z, et al. Metabolomics in the development and progression of rheumatoid arthritis: A systematic review. Joint Bone Spine 2020; 87(5): 425-30.
[http://dx.doi.org/10.1016/j.jbspin.2020.05.005] [PMID: 32473419]
[30]
Li J, Che N, Xu L, et al. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis. Clin Rheumatol 2018; 37(6): 1493-502.
[http://dx.doi.org/10.1007/s10067-018-4021-6] [PMID: 29442259]
[31]
Choudhary N, Bhatt LK, Prabhavalkar KS. Experimental animal models for rheumatoid arthritis. Immunopharmacol Immunotoxicol 2018; 40(3): 193-200.
[http://dx.doi.org/10.1080/08923973.2018.1434793] [PMID: 29433367]
[32]
Yue R, Zhao L, Hu Y, et al. Metabolomic study of collagen-induced arthritis in rats and the interventional effects of huang-lian-jie-du-tang, a traditional Chinese medicine. Evid Based Complement Alternat Med 2013; 2013: 1-12.
[http://dx.doi.org/10.1155/2013/439690] [PMID: 23533484]
[33]
Wang N, Dai R, Wang W, Peng Y, Zhao X, Bi K. Simultaneous profiling of eicosanoid metabolome in plasma by UPLC–MS/MS method: Application to identify potential makers for rheumatoid arthritis. Talanta 2016; 161: 157-64.
[http://dx.doi.org/10.1016/j.talanta.2016.08.038] [PMID: 27769393]
[34]
Rodríguez-Carrio J, Alperi-López M, López P, Ballina-García FJ, Suárez A. Non-esterified fatty acids profiling in rheumatoid arthritis: associations with clinical features and Th1 response. PLoS One 2016; 11(8): e0159573.
[http://dx.doi.org/10.1371/journal.pone.0159573] [PMID: 27487156]
[35]
Souto-Carneiro M, Tóth L, Behnisch R, et al. Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis. Ann Rheum Dis 2020; 79(4): 499-506.
[http://dx.doi.org/10.1136/annrheumdis-2019-216374] [PMID: 32079570]
[36]
Fuchs B, Schiller J, Wagner U, Häntzschel H, Arnold K. The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: Investigations by 31P NMR and MALDI-TOF MS. Clin Biochem 2005; 38(10): 925-33.
[http://dx.doi.org/10.1016/j.clinbiochem.2005.06.006] [PMID: 16043165]
[37]
Fuchs B. Mass spectrometry and inflammation—MS methods to study oxidation and enzyme-induced changes of phospholipids. Anal Bioanal Chem 2014; 406(5): 1291-306.
[http://dx.doi.org/10.1007/s00216-013-7534-5] [PMID: 24363111]
[38]
Nikitopoulou I, Oikonomou N, Karouzakis E, et al. Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. J Exp Med 2012; 209(5): 925-33.
[http://dx.doi.org/10.1084/jem.20112012] [PMID: 22493518]
[39]
Panfili E, Gerli R, Grohmann U, Pallotta MT. Amino acid metabolism in rheumatoid arthritis: Friend or foe? Biomolecules 2020; 10(9): 1280.
[http://dx.doi.org/10.3390/biom10091280] [PMID: 32899743]
[40]
Urbaniak B, Plewa S, Klupczynska A, Sikorska D, Samborski W, Kokot ZJ. Serum free amino acid levels in rheumatoid arthritis according to therapy and physical disability. Cytokine 2019; 113: 332-9.
[http://dx.doi.org/10.1016/j.cyto.2018.10.002] [PMID: 30337216]
[41]
Wei M, Ma Y, Liu Y, et al. Urinary metabolomics study on the anti-inflammation effects of flavonoids obtained from Glycyrrhiza. J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1086: 1-10.
[http://dx.doi.org/10.1016/j.jchromb.2018.04.007] [PMID: 29654981]
[42]
He M, Harms AC, van Wijk E, et al. Role of amino acids in rheumatoid arthritis studied by metabolomics. Int J Rheum Dis 2019; 22(1): 38-46.
[http://dx.doi.org/10.1111/1756-185X.13062] [PMID: 28328075]
[43]
Schroecksnadel K, Kaser S, Ledochowski M, et al. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J Rheumatol 2003; 30(9): 1935-9.
[PMID: 12966593]
[44]
Ozkan Y, Mete G, Sepici-Dincel A, Sepici V, Simsek B. Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients. Clin Rheumatol 2012; 31(1): 29-34.
[http://dx.doi.org/10.1007/s10067-011-1767-5] [PMID: 21556779]
[45]
Beaumont M, Neyrinck AM, Olivares M, et al. The gut microbiota metabolite indole alleviates liver inflammation in mice. FASEB J 2018; 32(12): 6681-93.
[http://dx.doi.org/10.1096/fj.201800544] [PMID: 29906245]
[46]
Chiang EP, Smith DE, Selhub J, Dallal G, Wang YC, Roubenoff R. Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res Ther 2005; 7(6): R1254-62.
[http://dx.doi.org/10.1186/ar1821] [PMID: 16277678]
[47]
Zheng T, Su S, Dai X, Zhang L, Duan JA, Ou-Yang Z. Metabolomic analysis of biochemical changes in the serum and urine of freund’s adjuvant-induced arthritis in rats after treatment with silkworm excrement. Molecules 2018; 23(6): 1490.
[http://dx.doi.org/10.3390/molecules23061490] [PMID: 29925785]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy